PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK
W. J. Valentine, J. M. Bottomley, A. J. Palmer, M. Brändle, V. Foos, R. Williams, J. A. Dormandy, J. Yates, M. H. Tan, M. Massi-Benedetti, on behalf of the PROactive Study GroupVolume:
24
Year:
2007
Language:
english
Pages:
21
DOI:
10.1111/j.1464-5491.2007.02188.x
File:
PDF, 440 KB
english, 2007